Skip to main content

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

By June 27, 2013December 20th, 2021No Comments

Informing the drug development and commercialization industry

Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical trial environment in South Korea, sponsor and service provider activities in the region, as well as the South Korean population health status.

“If South Korea is not already in a biopharmaceutical company’s strategic development plan, it should be” explained Andrew Schafer, President of ISR. “South Korea has seen exponential growth in the number of trials performed over past decade and new fair trade agreements along with a highly advanced, and connected, population has IMS calling for a 6.5% CAGR in drug spending through 2015.”

ISR’s new study utilizes on-the-ground industry interviews, Korean health statistics, and a comprehensive analysis to provide drug sponsors and their service providers with a novel, strategic tool to assess the geographic opportunity in South Korea.

What you’ll learn from ISR’s report:

  • How population characteristics, qualified investigators, and government policies and incentives make South Korea the 8th most active and most valuable country for clinical trial activity
  • On-the-ground insights from numerous high-level R&D employees in sponsor organizations and country heads from multinational CROs
  • Health statistics in Korea, including disease incidence and prevalence, use of imaging technologies, and use of medicines in major therapy areas
  • Compiled lists and contact details for pharma companies and principal investigators in South Korea

More information about this report is available on ISR’s website at

About Industry Standard Research

Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at, email, or follow us on Twitter @ISRreports.